世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

SND1抗体の世界市場インサイト、2029年までの予測


Global SND1 Antibody Market Insights, Forecast to 2029

SND1 抗体 LS-C669584 は、ヒト SND1 と結合するウサギのポリクローナル抗体です。69,000 Biotin conjugates。 世界のSND1抗体市場は、COVID-19とロシア・ウクライナ戦争の二重の影響を受けた2022年の100万米ド... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2023年8月11日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

SND1 抗体 LS-C669584 は、ヒト SND1 と結合するウサギのポリクローナル抗体です。69,000 Biotin conjugates。
世界のSND1抗体市場は、COVID-19とロシア・ウクライナ戦争の二重の影響を受けた2022年の100万米ドルに比べ、2023年には％プラスの成長を遂げ、100万米ドルに達すると予想されている。川下産業からの需要の増加に支えられ、SND1抗体産業は2029年に百万米ドルに達すると評価されている。2023年から2029年までのCAGRは％である。

世界的に、SND1抗体の主要メーカーは、Merck、Thermo Fisher Scientific、GeneTex、LifeSpan BioSciences、Leading Biology、RayBiotech、ProSci、Bio-Rad、Aviva Systems Biologyなどである。メルク、サーモフィッシャーサイエンティフィック、ジーンテックスが上位3社であり、2022年の売上高シェアは全体の1%である。
消費地域を考慮すると、2022年のSND1抗体の販売量は、北米、欧州、アジア太平洋地域に占める割合が高い。アジア太平洋地域は急成長を遂げ、2023年から2029年までのCAGRは%で、2029年の販売シェアは%になると推定される。さらに、中国はSND1抗体市場全体において重要な役割を担っており、業界関係者や投資家の注目を集めると推定される。

SND1抗体はモノクローナルとポリクローナルなどに分けられる。モノクローナルは市場の主流製品であり、2022年の世界売上シェアは%で、2029年にはその割合は%になると予想されます。
SND1抗体は、免疫化学（IHC）、免疫蛍光（IF）、免疫沈降（IP）、ウェスタンブロット（WB）など、様々な分野で広く使用されています。免疫化学(IHC)はSND1抗体産業の発展を最もサポートします。2022年、世界のSND1抗体の売上は、免疫化学（IHC）製剤が占め、その割合は2029年には％にまで達するだろう。

レポートの対象
本レポートは、2018年から2029年までの世界のSND1抗体市場の概要を紹介し、読者が世界のSND1抗体市場を多角的に包括的に理解することを目的としています。2018年から2029年までの地域別の売上高、収益、2018年から2023年までのメーカーの売上高、価格、収益、粗利益率などの項目を分析しています。さらに、2018年から2029年までの各地域における製品タイプおよび用途の売上高と収益も強調しています。

レポートに掲載されているメーカー、タイプ、アプリケーション、地域
企業別
ジーンテックス
ライフスパン・バイオサイエンシズ
リーディングバイオロジー
レイバイオテック
プロサイ
バイオ・ラッド
アビバシステムバイオロジー
ノーバス バイオロジカルズ
ABclonalテクノロジー
ベシル・ラボラトリーズ
プロテインテック・グループ
セント・ジョンズ研究所
バイオバイト
景傑PTMバイオラボ
武漢ファインバイオテック
北京ソーラーバイオ
タイプ別セグメント
モノクローナル
ポリクローナル
用途別セグメント
免疫化学（IHC）
免疫蛍光（IF）
免疫沈降（IP）
ウェスタンブロット（WB）
ELISA法
その他
地域別セグメント
米国・カナダ
米国
カナダ
中国
アジア（中国を除く）
日本
韓国
中国 台湾
東南アジア
インド
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
ラテンアメリカ、中東、アフリカ
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

章の概要
第1章：製品の定義、種類、用途の紹介
第2章：2018年から2029年までの地域別売上高および販売量分析
第3章：メーカーのSND1抗体工場分布、SND1抗体の商業日、提供される製品タイプ、M&A、拡大活動を含む、メーカーの売上、収益、価格分析
第4章：2018年から2029年までの世界のタイプ別製品売上高、収益、価格分析
第5章：2018年から2029年までの世界的な用途別製品売上高、収益および価格分析
第6章：米国・カナダにおける2018年から2029年までのタイプ別・用途別製品売上高、収益分析2018年から2029年までの米国＆カナダにおける各国別製品売上高、収益分析
第7章：ヨーロッパにおける2018年から2029年までの製品の販売、タイプ別および用途別収益分析。2018年から2029年までの欧州各国の製品売上高、収益分析
第8章：2018年から2029年までの中国における製品の売上高、タイプ別および用途別の収益分析。2018年から2029年までの中国の製品売上高、収益分析
第9章：2018年から2029年までのアジア（中国を除く）における製品売上高、タイプ別および用途別収益分析。2018年から2029年までのアジア（中国を除く）各国の製品売上高、収益分析
第10章：2018年から2029年までの中東、アフリカ、ラテンアメリカにおける製品の販売、タイプ別および用途別収益分析。2018年から2029年までの中東、アフリカ、ラテンアメリカの各国における製品売上高、収益分析。
第11章：メーカーの概要、企業の基本情報、主要事業、SND1抗体の紹介など。2018年から2023年までの各社のSND1抗体の売上高、収益、価格、およびグロスマージン
第12章：原材料、製造コストのような産業チェーン分析。市場チャネル、流通業者、顧客分析
第13章：市場機会と課題分析
第14章：SND1抗体に関するQYResearchの結論
第15章：QYResearchが採用した方法論とデータソース


ページTOPに戻る


目次

1 Study Coverage
1.1 SND1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global SND1 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global SND1 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global SND1 Antibody Sales Estimates and Forecasts 2018-2029
2.2 Global SND1 Antibody Revenue by Region
2.2.1 Global SND1 Antibody Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global SND1 Antibody Revenue by Region (2018-2023)
2.2.3 Global SND1 Antibody Revenue by Region (2024-2029)
2.2.4 Global SND1 Antibody Revenue Market Share by Region (2018-2029)
2.3 Global SND1 Antibody Sales Estimates and Forecasts 2018-2029
2.4 Global SND1 Antibody Sales by Region
2.4.1 Global SND1 Antibody Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global SND1 Antibody Sales by Region (2018-2023)
2.4.3 Global SND1 Antibody Sales by Region (2024-2029)
2.4.4 Global SND1 Antibody Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global SND1 Antibody Sales by Manufacturers
3.1.1 Global SND1 Antibody Sales by Manufacturers (2018-2023)
3.1.2 Global SND1 Antibody Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of SND1 Antibody in 2022
3.2 Global SND1 Antibody Revenue by Manufacturers
3.2.1 Global SND1 Antibody Revenue by Manufacturers (2018-2023)
3.2.2 Global SND1 Antibody Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by SND1 Antibody Revenue in 2022
3.3 Global Key Players of SND1 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global SND1 Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global SND1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of SND1 Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of SND1 Antibody, Product Offered and Application
3.8 Global Key Manufacturers of SND1 Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global SND1 Antibody Sales by Type
4.1.1 Global SND1 Antibody Historical Sales by Type (2018-2023)
4.1.2 Global SND1 Antibody Forecasted Sales by Type (2024-2029)
4.1.3 Global SND1 Antibody Sales Market Share by Type (2018-2029)
4.2 Global SND1 Antibody Revenue by Type
4.2.1 Global SND1 Antibody Historical Revenue by Type (2018-2023)
4.2.2 Global SND1 Antibody Forecasted Revenue by Type (2024-2029)
4.2.3 Global SND1 Antibody Revenue Market Share by Type (2018-2029)
4.3 Global SND1 Antibody Price by Type
4.3.1 Global SND1 Antibody Price by Type (2018-2023)
4.3.2 Global SND1 Antibody Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global SND1 Antibody Sales by Application
5.1.1 Global SND1 Antibody Historical Sales by Application (2018-2023)
5.1.2 Global SND1 Antibody Forecasted Sales by Application (2024-2029)
5.1.3 Global SND1 Antibody Sales Market Share by Application (2018-2029)
5.2 Global SND1 Antibody Revenue by Application
5.2.1 Global SND1 Antibody Historical Revenue by Application (2018-2023)
5.2.2 Global SND1 Antibody Forecasted Revenue by Application (2024-2029)
5.2.3 Global SND1 Antibody Revenue Market Share by Application (2018-2029)
5.3 Global SND1 Antibody Price by Application
5.3.1 Global SND1 Antibody Price by Application (2018-2023)
5.3.2 Global SND1 Antibody Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada SND1 Antibody Market Size by Type
6.1.1 US & Canada SND1 Antibody Sales by Type (2018-2029)
6.1.2 US & Canada SND1 Antibody Revenue by Type (2018-2029)
6.2 US & Canada SND1 Antibody Market Size by Application
6.2.1 US & Canada SND1 Antibody Sales by Application (2018-2029)
6.2.2 US & Canada SND1 Antibody Revenue by Application (2018-2029)
6.3 US & Canada SND1 Antibody Market Size by Country
6.3.1 US & Canada SND1 Antibody Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada SND1 Antibody Sales by Country (2018-2029)
6.3.3 US & Canada SND1 Antibody Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe SND1 Antibody Market Size by Type
7.1.1 Europe SND1 Antibody Sales by Type (2018-2029)
7.1.2 Europe SND1 Antibody Revenue by Type (2018-2029)
7.2 Europe SND1 Antibody Market Size by Application
7.2.1 Europe SND1 Antibody Sales by Application (2018-2029)
7.2.2 Europe SND1 Antibody Revenue by Application (2018-2029)
7.3 Europe SND1 Antibody Market Size by Country
7.3.1 Europe SND1 Antibody Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe SND1 Antibody Sales by Country (2018-2029)
7.3.3 Europe SND1 Antibody Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China SND1 Antibody Market Size
8.1.1 China SND1 Antibody Sales (2018-2029)
8.1.2 China SND1 Antibody Revenue (2018-2029)
8.2 China SND1 Antibody Market Size by Application
8.2.1 China SND1 Antibody Sales by Application (2018-2029)
8.2.2 China SND1 Antibody Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia SND1 Antibody Market Size by Type
9.1.1 Asia SND1 Antibody Sales by Type (2018-2029)
9.1.2 Asia SND1 Antibody Revenue by Type (2018-2029)
9.2 Asia SND1 Antibody Market Size by Application
9.2.1 Asia SND1 Antibody Sales by Application (2018-2029)
9.2.2 Asia SND1 Antibody Revenue by Application (2018-2029)
9.3 Asia SND1 Antibody Sales by Region
9.3.1 Asia SND1 Antibody Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia SND1 Antibody Revenue by Region (2018-2029)
9.3.3 Asia SND1 Antibody Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America SND1 Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America SND1 Antibody Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America SND1 Antibody Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America SND1 Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America SND1 Antibody Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America SND1 Antibody Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America SND1 Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America SND1 Antibody Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America SND1 Antibody Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America SND1 Antibody Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Merck SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Overview
11.2.3 Thermo Fisher Scientific SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Thermo Fisher Scientific SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 GeneTex
11.3.1 GeneTex Company Information
11.3.2 GeneTex Overview
11.3.3 GeneTex SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 GeneTex SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GeneTex Recent Developments
11.4 LifeSpan BioSciences
11.4.1 LifeSpan BioSciences Company Information
11.4.2 LifeSpan BioSciences Overview
11.4.3 LifeSpan BioSciences SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 LifeSpan BioSciences SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LifeSpan BioSciences Recent Developments
11.5 Leading Biology
11.5.1 Leading Biology Company Information
11.5.2 Leading Biology Overview
11.5.3 Leading Biology SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Leading Biology SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Leading Biology Recent Developments
11.6 RayBiotech
11.6.1 RayBiotech Company Information
11.6.2 RayBiotech Overview
11.6.3 RayBiotech SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 RayBiotech SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 RayBiotech Recent Developments
11.7 ProSci
11.7.1 ProSci Company Information
11.7.2 ProSci Overview
11.7.3 ProSci SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 ProSci SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ProSci Recent Developments
11.8 Bio-Rad
11.8.1 Bio-Rad Company Information
11.8.2 Bio-Rad Overview
11.8.3 Bio-Rad SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bio-Rad SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio-Rad Recent Developments
11.9 Aviva Systems Biology
11.9.1 Aviva Systems Biology Company Information
11.9.2 Aviva Systems Biology Overview
11.9.3 Aviva Systems Biology SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Aviva Systems Biology SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aviva Systems Biology Recent Developments
11.10 Novus Biologicals
11.10.1 Novus Biologicals Company Information
11.10.2 Novus Biologicals Overview
11.10.3 Novus Biologicals SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Novus Biologicals SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novus Biologicals Recent Developments
11.11 ABclonal Technology
11.11.1 ABclonal Technology Company Information
11.11.2 ABclonal Technology Overview
11.11.3 ABclonal Technology SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 ABclonal Technology SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ABclonal Technology Recent Developments
11.12 Bethyl Laboratories
11.12.1 Bethyl Laboratories Company Information
11.12.2 Bethyl Laboratories Overview
11.12.3 Bethyl Laboratories SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Bethyl Laboratories SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bethyl Laboratories Recent Developments
11.13 Proteintech Group
11.13.1 Proteintech Group Company Information
11.13.2 Proteintech Group Overview
11.13.3 Proteintech Group SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Proteintech Group SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Proteintech Group Recent Developments
11.14 St John's Laboratory
11.14.1 St John's Laboratory Company Information
11.14.2 St John's Laboratory Overview
11.14.3 St John's Laboratory SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 St John's Laboratory SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 St John's Laboratory Recent Developments
11.15 Biobyt
11.15.1 Biobyt Company Information
11.15.2 Biobyt Overview
11.15.3 Biobyt SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Biobyt SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Biobyt Recent Developments
11.16 Jingjie PTM BioLab
11.16.1 Jingjie PTM BioLab Company Information
11.16.2 Jingjie PTM BioLab Overview
11.16.3 Jingjie PTM BioLab SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Jingjie PTM BioLab SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Jingjie PTM BioLab Recent Developments
11.17 Wuhan Fine Biotech
11.17.1 Wuhan Fine Biotech Company Information
11.17.2 Wuhan Fine Biotech Overview
11.17.3 Wuhan Fine Biotech SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Wuhan Fine Biotech SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Wuhan Fine Biotech Recent Developments
11.18 Beijing Solarbio
11.18.1 Beijing Solarbio Company Information
11.18.2 Beijing Solarbio Overview
11.18.3 Beijing Solarbio SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Beijing Solarbio SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Beijing Solarbio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 SND1 Antibody Industry Chain Analysis
12.2 SND1 Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 SND1 Antibody Production Mode & Process
12.4 SND1 Antibody Sales and Marketing
12.4.1 SND1 Antibody Sales Channels
12.4.2 SND1 Antibody Distributors
12.5 SND1 Antibody Customers
13 Market Dynamics
13.1 SND1 Antibody Industry Trends
13.2 SND1 Antibody Market Drivers
13.3 SND1 Antibody Market Challenges
13.4 SND1 Antibody Market Restraints
14 Key Findings in The Global SND1 Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る


　

Summary

SND1 antibody LS-C669584 is a rabbit polyclonal that binds human SND1. 69,000 Biotin conjugates。
Global SND1 Antibody market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, SND1 Antibody industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2023 to 2029.

Globally, SND1 Antibody key manufacturers include Merck, Thermo Fisher Scientific, GeneTex, LifeSpan BioSciences, Leading Biology, RayBiotech, ProSci, Bio-Rad and Aviva Systems Biology, etc. Merck, Thermo Fisher Scientific, GeneTex are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of SND1 Antibody were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole SND1 Antibody market and estimated to attract more attentions from industry insiders and investors.

SND1 Antibody can be divided into Monoclonal and Polyclonal, etc. Monoclonal is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
SND1 Antibody is widely used in various fields, such as Immunochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP) and Western Blot (WB), etc. Immunochemistry (IHC) provides greatest supports to the SND1 Antibody industry development. In 2022, global % sales of SND1 Antibody went into Immunochemistry (IHC) filed and the proportion will reach to % in 2029.

Report Covers:
This report presents an overview of global SND1 Antibody market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global SND1 Antibody market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.

Manufacturers, Type, Application and Regions Listed in the Report:
By Company
GeneTex
LifeSpan BioSciences
Leading Biology
RayBiotech
ProSci
Bio-Rad
Aviva Systems Biology
Novus Biologicals
ABclonal Technology
Bethyl Laboratories
Proteintech Group
St John's Laboratory
Biobyt
Jingjie PTM BioLab
Wuhan Fine Biotech
Beijing Solarbio
Segment by Type
Monoclonal
Polyclonal
Segment by Application
Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Product definition, type and application introduction
Chapter 2: Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3: Manufacturers’ sales, revenue and price analysis, including manufacturers’ SND1 Antibody plant distribution, commercial date of SND1 Antibody, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4: Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5: Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6: Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7: Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8: Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9: Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10: Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11: Manufacturers’ outline, covering company’s basic information, major business, SND1 Antibody introduction, etc. SND1 Antibody Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12: Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13: Market opportunities and challenges analysis
Chapter 14: QYResearch’s Conclusions of SND1 Antibody
Chapter 15: Methodology and Data Sources adopted by QYResearch



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 SND1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global SND1 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global SND1 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global SND1 Antibody Sales Estimates and Forecasts 2018-2029
2.2 Global SND1 Antibody Revenue by Region
2.2.1 Global SND1 Antibody Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global SND1 Antibody Revenue by Region (2018-2023)
2.2.3 Global SND1 Antibody Revenue by Region (2024-2029)
2.2.4 Global SND1 Antibody Revenue Market Share by Region (2018-2029)
2.3 Global SND1 Antibody Sales Estimates and Forecasts 2018-2029
2.4 Global SND1 Antibody Sales by Region
2.4.1 Global SND1 Antibody Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global SND1 Antibody Sales by Region (2018-2023)
2.4.3 Global SND1 Antibody Sales by Region (2024-2029)
2.4.4 Global SND1 Antibody Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global SND1 Antibody Sales by Manufacturers
3.1.1 Global SND1 Antibody Sales by Manufacturers (2018-2023)
3.1.2 Global SND1 Antibody Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of SND1 Antibody in 2022
3.2 Global SND1 Antibody Revenue by Manufacturers
3.2.1 Global SND1 Antibody Revenue by Manufacturers (2018-2023)
3.2.2 Global SND1 Antibody Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by SND1 Antibody Revenue in 2022
3.3 Global Key Players of SND1 Antibody, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global SND1 Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global SND1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of SND1 Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of SND1 Antibody, Product Offered and Application
3.8 Global Key Manufacturers of SND1 Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global SND1 Antibody Sales by Type
4.1.1 Global SND1 Antibody Historical Sales by Type (2018-2023)
4.1.2 Global SND1 Antibody Forecasted Sales by Type (2024-2029)
4.1.3 Global SND1 Antibody Sales Market Share by Type (2018-2029)
4.2 Global SND1 Antibody Revenue by Type
4.2.1 Global SND1 Antibody Historical Revenue by Type (2018-2023)
4.2.2 Global SND1 Antibody Forecasted Revenue by Type (2024-2029)
4.2.3 Global SND1 Antibody Revenue Market Share by Type (2018-2029)
4.3 Global SND1 Antibody Price by Type
4.3.1 Global SND1 Antibody Price by Type (2018-2023)
4.3.2 Global SND1 Antibody Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global SND1 Antibody Sales by Application
5.1.1 Global SND1 Antibody Historical Sales by Application (2018-2023)
5.1.2 Global SND1 Antibody Forecasted Sales by Application (2024-2029)
5.1.3 Global SND1 Antibody Sales Market Share by Application (2018-2029)
5.2 Global SND1 Antibody Revenue by Application
5.2.1 Global SND1 Antibody Historical Revenue by Application (2018-2023)
5.2.2 Global SND1 Antibody Forecasted Revenue by Application (2024-2029)
5.2.3 Global SND1 Antibody Revenue Market Share by Application (2018-2029)
5.3 Global SND1 Antibody Price by Application
5.3.1 Global SND1 Antibody Price by Application (2018-2023)
5.3.2 Global SND1 Antibody Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada SND1 Antibody Market Size by Type
6.1.1 US & Canada SND1 Antibody Sales by Type (2018-2029)
6.1.2 US & Canada SND1 Antibody Revenue by Type (2018-2029)
6.2 US & Canada SND1 Antibody Market Size by Application
6.2.1 US & Canada SND1 Antibody Sales by Application (2018-2029)
6.2.2 US & Canada SND1 Antibody Revenue by Application (2018-2029)
6.3 US & Canada SND1 Antibody Market Size by Country
6.3.1 US & Canada SND1 Antibody Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada SND1 Antibody Sales by Country (2018-2029)
6.3.3 US & Canada SND1 Antibody Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe SND1 Antibody Market Size by Type
7.1.1 Europe SND1 Antibody Sales by Type (2018-2029)
7.1.2 Europe SND1 Antibody Revenue by Type (2018-2029)
7.2 Europe SND1 Antibody Market Size by Application
7.2.1 Europe SND1 Antibody Sales by Application (2018-2029)
7.2.2 Europe SND1 Antibody Revenue by Application (2018-2029)
7.3 Europe SND1 Antibody Market Size by Country
7.3.1 Europe SND1 Antibody Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe SND1 Antibody Sales by Country (2018-2029)
7.3.3 Europe SND1 Antibody Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China SND1 Antibody Market Size
8.1.1 China SND1 Antibody Sales (2018-2029)
8.1.2 China SND1 Antibody Revenue (2018-2029)
8.2 China SND1 Antibody Market Size by Application
8.2.1 China SND1 Antibody Sales by Application (2018-2029)
8.2.2 China SND1 Antibody Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia SND1 Antibody Market Size by Type
9.1.1 Asia SND1 Antibody Sales by Type (2018-2029)
9.1.2 Asia SND1 Antibody Revenue by Type (2018-2029)
9.2 Asia SND1 Antibody Market Size by Application
9.2.1 Asia SND1 Antibody Sales by Application (2018-2029)
9.2.2 Asia SND1 Antibody Revenue by Application (2018-2029)
9.3 Asia SND1 Antibody Sales by Region
9.3.1 Asia SND1 Antibody Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia SND1 Antibody Revenue by Region (2018-2029)
9.3.3 Asia SND1 Antibody Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America SND1 Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America SND1 Antibody Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America SND1 Antibody Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America SND1 Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America SND1 Antibody Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America SND1 Antibody Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America SND1 Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America SND1 Antibody Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America SND1 Antibody Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America SND1 Antibody Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 Merck SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merck Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Overview
11.2.3 Thermo Fisher Scientific SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 Thermo Fisher Scientific SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Fisher Scientific Recent Developments
11.3 GeneTex
11.3.1 GeneTex Company Information
11.3.2 GeneTex Overview
11.3.3 GeneTex SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 GeneTex SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GeneTex Recent Developments
11.4 LifeSpan BioSciences
11.4.1 LifeSpan BioSciences Company Information
11.4.2 LifeSpan BioSciences Overview
11.4.3 LifeSpan BioSciences SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 LifeSpan BioSciences SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 LifeSpan BioSciences Recent Developments
11.5 Leading Biology
11.5.1 Leading Biology Company Information
11.5.2 Leading Biology Overview
11.5.3 Leading Biology SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Leading Biology SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Leading Biology Recent Developments
11.6 RayBiotech
11.6.1 RayBiotech Company Information
11.6.2 RayBiotech Overview
11.6.3 RayBiotech SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 RayBiotech SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 RayBiotech Recent Developments
11.7 ProSci
11.7.1 ProSci Company Information
11.7.2 ProSci Overview
11.7.3 ProSci SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 ProSci SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 ProSci Recent Developments
11.8 Bio-Rad
11.8.1 Bio-Rad Company Information
11.8.2 Bio-Rad Overview
11.8.3 Bio-Rad SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Bio-Rad SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Bio-Rad Recent Developments
11.9 Aviva Systems Biology
11.9.1 Aviva Systems Biology Company Information
11.9.2 Aviva Systems Biology Overview
11.9.3 Aviva Systems Biology SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Aviva Systems Biology SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Aviva Systems Biology Recent Developments
11.10 Novus Biologicals
11.10.1 Novus Biologicals Company Information
11.10.2 Novus Biologicals Overview
11.10.3 Novus Biologicals SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 Novus Biologicals SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Novus Biologicals Recent Developments
11.11 ABclonal Technology
11.11.1 ABclonal Technology Company Information
11.11.2 ABclonal Technology Overview
11.11.3 ABclonal Technology SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 ABclonal Technology SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 ABclonal Technology Recent Developments
11.12 Bethyl Laboratories
11.12.1 Bethyl Laboratories Company Information
11.12.2 Bethyl Laboratories Overview
11.12.3 Bethyl Laboratories SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 Bethyl Laboratories SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bethyl Laboratories Recent Developments
11.13 Proteintech Group
11.13.1 Proteintech Group Company Information
11.13.2 Proteintech Group Overview
11.13.3 Proteintech Group SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.13.4 Proteintech Group SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Proteintech Group Recent Developments
11.14 St John's Laboratory
11.14.1 St John's Laboratory Company Information
11.14.2 St John's Laboratory Overview
11.14.3 St John's Laboratory SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.14.4 St John's Laboratory SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 St John's Laboratory Recent Developments
11.15 Biobyt
11.15.1 Biobyt Company Information
11.15.2 Biobyt Overview
11.15.3 Biobyt SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.15.4 Biobyt SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Biobyt Recent Developments
11.16 Jingjie PTM BioLab
11.16.1 Jingjie PTM BioLab Company Information
11.16.2 Jingjie PTM BioLab Overview
11.16.3 Jingjie PTM BioLab SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.16.4 Jingjie PTM BioLab SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Jingjie PTM BioLab Recent Developments
11.17 Wuhan Fine Biotech
11.17.1 Wuhan Fine Biotech Company Information
11.17.2 Wuhan Fine Biotech Overview
11.17.3 Wuhan Fine Biotech SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.17.4 Wuhan Fine Biotech SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Wuhan Fine Biotech Recent Developments
11.18 Beijing Solarbio
11.18.1 Beijing Solarbio Company Information
11.18.2 Beijing Solarbio Overview
11.18.3 Beijing Solarbio SND1 Antibody Sales, Price, Revenue and Gross Margin (2018-2023)
11.18.4 Beijing Solarbio SND1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Beijing Solarbio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 SND1 Antibody Industry Chain Analysis
12.2 SND1 Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 SND1 Antibody Production Mode & Process
12.4 SND1 Antibody Sales and Marketing
12.4.1 SND1 Antibody Sales Channels
12.4.2 SND1 Antibody Distributors
12.5 SND1 Antibody Customers
13 Market Dynamics
13.1 SND1 Antibody Industry Trends
13.2 SND1 Antibody Market Drivers
13.3 SND1 Antibody Market Challenges
13.4 SND1 Antibody Market Restraints
14 Key Findings in The Global SND1 Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療）の最新刊レポート

QYResearch社の医療分野での最新刊レポート

本レポートと同じKEY WORD（antibody）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/15　10:26

157.84 円

166.62 円

202.61 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.